Showing results (151-160 of 247) with videos related to
Sort By:
Pageof 25
Clinical Pharmacology and Therapeutics|March 1, 1991
Prospective pharmacokinetically based development of effective infusion regimens for ACC-9358, a new antiarrhythmic drugH N Pavlou, C Funck-Brentano, M D Lineberry, et al.The American Journal of Cardiology|May 1, 1988
Electrophysiologic effects of intravenous and oral sotalol for sustained ventricular tachycardia secondary to coronary artery diseaseH A Kopelman, R L Woosley, J T Lee, et al.Circulation Research|November 1, 1994
Block of IKs, the slow component of the delayed rectifier K+ current, by the diuretic agent indapamide in guinea pig myocytesJ Turgeon, P Daleau, P B Bennett, et al.Journal of Cardiovascular Pharmacology|July 1, 1984
Electrophysiology of O-demethyl encainide in a canine model of sustained ventricular tachycardiaD M Roden, A K Dawson, H J Duff, et al.American Heart Journal|October 1, 1983
Amiodarone dosing: a proposal based on its pharmacokineticsL A Siddoway, C B McAllister, G R Wilkinson, et al.Annals of Internal Medicine|January 1, 1984
A new method for constant plasma drug concentrations: application to lidocaineJ G Riddell, C B McAllister, G R Wilkinson, et al.Circulation|February 1, 1988
Antiarrhythmic activity, electrocardiographic effects and pharmacokinetics of the encainide metabolites O-desmethyl encainide and 3-methoxy-O-desmethyl encainide in manJ T Barbey, K A Thompson, D S Echt, et al.The Journal of Pharmacology and Experimental Therapeutics|April 25, 2000
Characterization of the major metabolites of verapamil as substrates and inhibitors of P-glycoproteinC Pauli-Magnus, O von Richter, O Burk, et al.International Journal of Clinical Pharmacology and Therapeutics|September 26, 2006
Valdecoxib does not interfere with the CYP2D6 substrate metoprololU Werner, C Lamprecht, D Werner, et al.Circulation Research|November 1, 1994
K+ currents and K+ channel mRNA in cultured atrial cardiac myocytes (AT-1 cells)T Yang, M S Wathen, A Felipe, et al.Pageof 25